ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681633 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681633; 2) Community: the network communities that were significantly associated with the response to NSC 681633; 3) Molecule: the relationships between components within communities and NSC 681633; 4) MDR: the compounds that were significantly associated with the NSC 681633.

NSC Compound Enrichment Correlation
NSC 681645 Camptothecin Derivative 0.0164116791870034 0.9212262
NSC 682763 Null 0.0164116791870034 0.17272673
NSC 683558 Camptothecin Derivative 0.0164116791870034 0.88478884
NSC 686940 Null 0.0164116791870034 0.094499901
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.0164116791870034 0.50213365
NSC 704533 Null 0.0164116791870034 0.69023628
NSC 720296 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-methyl)cyclohexane 0.0164116791870034 0.23073212
NSC 728091 6-[(3-Hydroxy)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methy lenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0164116791870034 0.61890248
NSC 735037 Camptothecin Derivative 0.0164116791870034 0.85198387
NSC 740524 6-(3-Azidopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0164116791870034 0.71266189
Total:53  Current:20    [First] [Prev] [Next] [Last]